199 related articles for article (PubMed ID: 25149909)
1. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
[TBL] [Abstract][Full Text] [Related]
2. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations in the gene encoding prothrombin corresponding to Arg596 cause antithrombin resistance and thrombomodulin resistance.
Takagi Y; Murata M; Kozuka T; Nakata Y; Hasebe R; Tamura S; Takagi A; Matsushita T; Saito H; Kojima T
Thromb Haemost; 2016 Nov; 116(6):1022-1031. PubMed ID: 27604259
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis from a prothrombin mutation conveying antithrombin resistance.
Miyawaki Y; Suzuki A; Fujita J; Maki A; Okuyama E; Murata M; Takagi A; Murate T; Kunishima S; Sakai M; Okamoto K; Matsushita T; Naoe T; Saito H; Kojima T
N Engl J Med; 2012 Jun; 366(25):2390-6. PubMed ID: 22716977
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombin resistance: a new mechanism of inherited thrombophilia].
Kojima T; Takagi A; Murata M; Takagi Y
Rinsho Ketsueki; 2015 Jun; 56(6):632-8. PubMed ID: 26256872
[TBL] [Abstract][Full Text] [Related]
6. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
7. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
8. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
9. Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.
Wu QY; Sheehan JP; Tsiang M; Lentz SR; Birktoft JJ; Sadler JE
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6775-9. PubMed ID: 1650482
[TBL] [Abstract][Full Text] [Related]
10. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Shim K; Zhu H; Westfield LA; Sadler JE
Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.
Ding Q; Yang L; Zhao X; Wu W; Wang X; Rezaie AR
Thromb Haemost; 2017 Feb; 117(3):479-490. PubMed ID: 27975099
[TBL] [Abstract][Full Text] [Related]
12. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
Tanaka KA; Szlam F; Levy JH
Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin Resistance Rescues Clotting Defect of Homozygous Prothrombin-Y510N Dysprothrombinemia.
Lu Y; Villoutreix BO; Biswas I; Ding Q; Wang X; Rezaie AR
Thromb Haemost; 2022 May; 122(5):679-691. PubMed ID: 34256393
[TBL] [Abstract][Full Text] [Related]
14. In vitro exploration of latent prothrombin mutants conveying antithrombin resistance.
Tamura S; Murata-Kawakami M; Takagi Y; Suzuki S; Katsumi A; Takagi A; Kojima T
Thromb Res; 2017 Nov; 159():33-38. PubMed ID: 28961453
[TBL] [Abstract][Full Text] [Related]
15. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
16. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
[TBL] [Abstract][Full Text] [Related]
17. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
[TBL] [Abstract][Full Text] [Related]
19. Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
Binetti BM; Rotunno C; Tripodi A; Asti D; Semeraro F; Semeraro N; Colucci M
Thromb Haemost; 2006 Apr; 95(4):606-11. PubMed ID: 16601829
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
